摘要:
Objective methods for diagnosing a predisposition to developing prostate cancer (PRC) are described herein. In one embodiment, the diagnostic method involves the determining a expression level of PRC-associated gene that discriminate between PRC and PIN. The present invention further provides methods of screening for therapeutic agents useful in the treatment of PRC, methods of treating PRC.
摘要:
Using the proteins of the present invention, DNAs encoding the proteins, and antibodies recognizing the proteins, detection methods for diseases relating to the novel insulin-like growth factor binding proteins of the present invention, as well as diagnostic agents, preventive agents, and therapeutic agents for diseases relating to the proteins of the present invention can be provided.
摘要:
Objective methods for detecting and diagnosing Chronic myeloid leukemia (CML) are described herein. In one embodiment, the diagnostic method involves the determining a expression level of CML-associated gene that discriminate between CML and normal cell. The present invention further provides methods of screening for therapeutic agents useful in the treatment of CML, methods of treating CML and method of vaccinating a subject against CML.
摘要:
A method for detecting a genetic polymorphism(s), comprising creating oligonucleotide probes and/or oligonucleotide primers so that the probes and/or primers contain a polymorphic site(s) present in a gene encoding a receptor or a sequence complementary thereto or so that the polymorphic site(s) is/are contained in the amplified fragment when at least one of said gene encoding the receptor and said sequence complementary thereto is amplified; and detecting at least one genetic polymorphism in a gene of a subject encoding the receptor using the resultant oligonucleotide probes and/or oligonucleotide primers.
摘要:
A method for detecting a genetic polymorphism(s) in a gene encoding cytochrome P450 using as oligonucleotide probes and/or oligonucleotide primers at least one sequence selected from the group consisting of an at least 13 nucleotide sequence within any of the nucleotide sequences as shown in SEQ ID NOS: 1 through 215, said at least 13 nucleotide sequence containing the 21st nucleotide, or a sequence complementary to said at least 13 nucleotide sequence.
摘要翻译:用于使用寡核苷酸探针和/或寡核苷酸引物检测编码细胞色素P450的基因中的遗传多态性的方法,所述寡核苷酸探针和/或寡核苷酸引物至少一个选自下列任一核苷酸序列中的至少13个核苷酸序列的序列,如 SEQ ID NO:1至215,所述至少13个核苷酸序列含有第21个核苷酸,或与所述至少13个核苷酸序列互补的序列。
摘要:
Using the proteins of the present invention, DNAs encoding the proteins, and antibodies recognizing the proteins, detection methods for diseases relating to the novel insulin-like growth factor binding proteins of the present invention, as well as diagnostic agents, preventive agents, and therapeutic agents for diseases relating to the proteins of the present invention can be provided.
摘要:
Objective methods for detecting and diagnosing testicular seminoma (TS) arc described herein. In one embodiment, the diagnostic method involves the determining a expression level of TS -associated gene that discriminate between TS and nomal cell. The present invention further provides methods of screening for therapeutic agents useful in the treatment of TS, methods of treating TS and method of vaccinating a subject against TS.
摘要:
Disclosed are methods of detecting metastasis of colorectal cancer using differentially expressed genes. Also disclosed are methods of identifying agents for treating colorectal cancer or preventing metastasis of colorectal cancer.
摘要:
The present invention relates to the use of cytoxicity based on the effector function of anti-FAM3D antibodies. Specifically, the present invention provides methods and pharmaceutical compositions that comprise an anti-FAM3D antibody as an active ingredient for damaging FAM3D-expressing cells using antibody effector function. Since FAM3D is strongly expressed in lung cancer cells, the present invention is useful in lung cancer therapies.
摘要:
A DNA encoding a novel steroid hormone receptor-like protein was obtained from a human fetal lung cDNA library, and its structure was determined. Further, the protein encoded by the gene was isolated, identified, and designated as an ECDN protein. Furthermore, a protein encoded by a DNA lacking a part of the above gene was isolated, identified, and designated as an ECDN paucimolecular protein.It was proven that the ECDN paucimolecular protein was expressed in various cancer cells. Therefore, it is expected that it becomes possible to diagnose and treat cancers by analyzing the expression of the ECDN protein and the ECDN paucimolecular protein in a subject tissue. Furthermore, attained to develop novel pharmaceuticals can be developed by finding natural and synthetic compounds capable of binding specifically to the ECDN protein and the ECDN paucimolecular protein.